[go: up one dir, main page]

RU2000124123A - METHOD FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES - Google Patents

METHOD FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES

Info

Publication number
RU2000124123A
RU2000124123A RU2000124123/14A RU2000124123A RU2000124123A RU 2000124123 A RU2000124123 A RU 2000124123A RU 2000124123/14 A RU2000124123/14 A RU 2000124123/14A RU 2000124123 A RU2000124123 A RU 2000124123A RU 2000124123 A RU2000124123 A RU 2000124123A
Authority
RU
Russia
Prior art keywords
treatment
prevention
cardiovascular diseases
cardiovascular
streptokinase
Prior art date
Application number
RU2000124123/14A
Other languages
Russian (ru)
Other versions
RU2194520C2 (en
Inventor
Валерий Александрович Черешнев
Агния Аркадьевна Морова
Ирина Николаевна Рямзина
Original Assignee
Валерий Александрович Черешнев
Агния Аркадьевна Морова
Ирина Николаевна Рямзина
Filing date
Publication date
Application filed by Валерий Александрович Черешнев, Агния Аркадьевна Морова, Ирина Николаевна Рямзина filed Critical Валерий Александрович Черешнев
Priority to RU2000124123A priority Critical patent/RU2194520C2/en
Priority claimed from RU2000124123A external-priority patent/RU2194520C2/en
Publication of RU2000124123A publication Critical patent/RU2000124123A/en
Application granted granted Critical
Publication of RU2194520C2 publication Critical patent/RU2194520C2/en

Links

Claims (1)

Способ лечения и профилактики сердечно-сосудистых заболеваний, отличающийся тем, что пациенту вводят внутрикожно взвесь живых клеток аттенуированного стрептокиназоактивного музейного штамма симбионтных бактерий в дозе 50-100 ммт, двукратно - с профилактической целью, трехкратно и более на фоне традиционной терапии - при лечении сердечно-сосудистых заболеваний.A method for the treatment and prevention of cardiovascular diseases, characterized in that a patient is injected intracutaneously with a suspension of living cells of an attenuated streptokinase-active museum strain of symbiotic bacteria at a dose of 50-100 mmt, twice for prophylactic purposes, three times or more against the background of traditional therapy - in the treatment of cardiovascular vascular disease.
RU2000124123A 2000-09-20 2000-09-20 Method for treating and preventing cardiovascular diseases RU2194520C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2000124123A RU2194520C2 (en) 2000-09-20 2000-09-20 Method for treating and preventing cardiovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000124123A RU2194520C2 (en) 2000-09-20 2000-09-20 Method for treating and preventing cardiovascular diseases

Publications (2)

Publication Number Publication Date
RU2000124123A true RU2000124123A (en) 2002-08-20
RU2194520C2 RU2194520C2 (en) 2002-12-20

Family

ID=20240271

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000124123A RU2194520C2 (en) 2000-09-20 2000-09-20 Method for treating and preventing cardiovascular diseases

Country Status (1)

Country Link
RU (1) RU2194520C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801452A (en) * 1986-05-15 1989-01-31 Hunter Robert L Fibrinolytic composition
RU2086246C1 (en) * 1995-09-20 1997-08-10 Институт экологии и генетики микроорганизмов Уральского отделения РАН Method of preparing enzymotherapeutic, antiviral and immunomodulating preparation and enzymotherapeutic, antiviral and immunomodulating preparation

Similar Documents

Publication Publication Date Title
SE9702860D0 (en) New use
TR200102059T2 (en) The use of bifidobacteria in the treatment of inflammatory diseases
CA2400801A1 (en) Treatment of congestive heart failure by pretreated autologous blood
WO2002091997A3 (en) Oncolytic virus therapy
MXPA05000880A (en) Probiotics for gut neuromuscular functions.
EP1790728A3 (en) Imaging, diagnosis and treatment of disease
Lightwood The economics of smoking and cardiovascular disease
RU99115515A (en) MEANS FOR CORRECTION OF HEMATOPROBISM AND PREVENTION OF DYSPEPSIA OF NEWBORN CALVES
MD990258A (en) Method of treatment of the acute viral hepatitis B
ES1025328Y (en) DOUBLE FACE DOLL AND VARIABLE HEIGHT ADAPTABLE TO THE BODY AND HEIGHT OF THE USER.
WO2004037233A3 (en) Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
RU2000124123A (en) METHOD FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
AU2001232736A1 (en) Protein c derivatives
CA2305183A1 (en) Postsurgical treatment with dichloroacetate
CA2310926A1 (en) A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
WO2004072263A3 (en) Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
WO2001036462A3 (en) Protein c derivatives
MXPA03000033A (en) Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies.
MX291518B (en) Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease.
CN2420047Y (en) Health-care mahjong
Lord Sweet healing
Paul Milieu therapy.
WO2002028430A3 (en) Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
Lichstein Relaxation training.
SCHULMAN Optimal duration of anticoagulation therapy after venous thromboembolism